SMTI
Sanara MedTech Inc (SMTI)
Healthcare • NASDAQ • $22.89+5.24%
- Symbol
- SMTI
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Price
- $22.89
- Daily Change
- +5.24%
- Market Cap
- $201.79M
- Trailing P/E
- 367.00
- Forward P/E
- 40.78
- 52W High
- $35.95
- 52W Low
- $16.05
- Analyst Target
- $34.33
- Dividend Yield
- N/A
- Beta
- 1.19
Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical solutions to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY Tissue Repair Graft(FORTIFY TRG), a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; BiFORM, an osteoconductive, bioactive, porous implant that allows bony ingrowth across the graft site and it can be used as a strip or molded into a putty to fill a bone defect…
Company websiteResearch SMTI on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.